CZ265896A3 - Tryptase inhibitor, its use and pharmaceutical compositions containing thereof - Google Patents

Tryptase inhibitor, its use and pharmaceutical compositions containing thereof Download PDF

Info

Publication number
CZ265896A3
CZ265896A3 CZ962658A CZ265896A CZ265896A3 CZ 265896 A3 CZ265896 A3 CZ 265896A3 CZ 962658 A CZ962658 A CZ 962658A CZ 265896 A CZ265896 A CZ 265896A CZ 265896 A3 CZ265896 A3 CZ 265896A3
Authority
CZ
Czechia
Prior art keywords
virus
alp
viral
tryptase
clara
Prior art date
Application number
CZ962658A
Other languages
Czech (cs)
English (en)
Inventor
Hiroshi Kido
Masato Tashiro
Shozaburo Sekido
Original Assignee
Tokyo Tanabe Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co filed Critical Tokyo Tanabe Co
Publication of CZ265896A3 publication Critical patent/CZ265896A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CZ962658A 1994-03-23 1995-03-20 Tryptase inhibitor, its use and pharmaceutical compositions containing thereof CZ265896A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5223794 1994-03-23

Publications (1)

Publication Number Publication Date
CZ265896A3 true CZ265896A3 (en) 1997-06-11

Family

ID=12909121

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ962658A CZ265896A3 (en) 1994-03-23 1995-03-20 Tryptase inhibitor, its use and pharmaceutical compositions containing thereof

Country Status (16)

Country Link
US (1) US5900401A (en:Method)
EP (1) EP0804930A1 (en:Method)
KR (1) KR970701561A (en:Method)
CN (1) CN1144488A (en:Method)
AU (1) AU689559B2 (en:Method)
BG (1) BG100835A (en:Method)
BR (1) BR9507165A (en:Method)
CA (1) CA2186111A1 (en:Method)
CZ (1) CZ265896A3 (en:Method)
FI (1) FI963753A0 (en:Method)
HU (1) HUT75660A (en:Method)
NZ (1) NZ282488A (en:Method)
PL (1) PL316444A1 (en:Method)
RO (1) RO113431B1 (en:Method)
SK (1) SK119896A3 (en:Method)
WO (1) WO1995025539A1 (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69810800T2 (de) * 1997-10-07 2003-09-18 Boehringer Ingelheim (Canada) Ltd., Laval Azetidinonderivate zur behandlung von hcmv entzündungen
JP2001519329A (ja) * 1997-10-07 2001-10-23 ベーリンガー インゲルハイム （カナダ） リミテッド Ｈｃｍｖ感染症の治療用のアゼチジノン誘導体
DK1021404T3 (da) * 1997-10-07 2003-03-24 Boehringer Ingelheim Ca Ltd Azetidinonderivater til behandling af HCMV-infektioner
US8679462B2 (en) * 2002-04-11 2014-03-25 Saeed Rezakhany Methods of preventing respiratory infections
WO2021181037A1 (fr) * 2020-03-09 2021-09-16 Organes Tissus Regeneration Reparation Remplacement Composition pour le traitement de lesions du systeme respiratoire

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000077A1 (en) * 1984-06-14 1986-01-03 Cortech, Inc. Human leukocyte elastase inhibitors prepared from pyogenic bacteria and methods for their purification
HU204563B (en) * 1984-12-06 1992-01-28 Synergen Biolog Inc Process for producing recombinant serine-protease inhibitors and dns sequencyes for them
JPS62501291A (ja) * 1984-12-06 1987-05-21 サイナ−ゲン　バイオロジカルズ，インコ−ポレ−テツド 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
EP0205555B2 (en) * 1984-12-06 2002-04-10 Amgen Inc. Serine protease inhibitors and methods for isolation of same
DE3600571A1 (de) * 1986-01-10 1987-08-06 Gruenenthal Gmbh Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel
US5290762A (en) * 1986-12-24 1994-03-01 John Lezdey Treatment of inflammation
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
DE3841873A1 (de) * 1988-12-13 1990-06-21 Gruenenthal Gmbh Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen
JP3961029B2 (ja) * 1992-06-24 2007-08-15 博 木戸 インフルエンザウィルス感染防止剤
US5334141A (en) * 1992-06-26 1994-08-02 Medrad, Inc. Extravasation detection system and apparatus
RU2126266C1 (ru) * 1992-09-09 1999-02-20 Амген Боулдер, Инк. Способ ингибирования ретровирусной инфекции (варианты), ингибитор протеазы, кодирующая его нуклеиновая кислота и способ рекомбинантного продуцирования серинового ингибитора
US5376633A (en) * 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase

Also Published As

Publication number Publication date
FI963753A7 (fi) 1996-09-20
NZ282488A (en) 1999-09-29
HUT75660A (en) 1997-05-28
BR9507165A (pt) 1997-09-09
EP0804930A1 (en) 1997-11-05
FI963753L (fi) 1996-09-20
RO113431B1 (ro) 1998-07-30
US5900401A (en) 1999-05-04
AU689559B2 (en) 1998-04-02
AU1961195A (en) 1995-10-09
EP0804930A4 (en:Method) 1997-11-05
BG100835A (bg) 1997-06-30
WO1995025539A1 (en) 1995-09-28
CA2186111A1 (en) 1995-09-28
FI963753A0 (fi) 1996-09-20
SK119896A3 (en) 1997-04-09
CN1144488A (zh) 1997-03-05
HU9602598D0 (en) 1996-11-28
PL316444A1 (en) 1997-01-20
KR970701561A (ko) 1997-04-12

Similar Documents

Publication Publication Date Title
Klenk et al. Host cell proteases controlling virus pathogenicity
CN101848719B (zh) 流感抑制组合物和方法
ES2606541T3 (es) Proteína CC10 humana recombinante para el tratamiento de la gripe
RU2711080C2 (ru) Комбинированный аэрозольный состав на основе ингибиторов протеаз и его получение
CZ265896A3 (en) Tryptase inhibitor, its use and pharmaceutical compositions containing thereof
US8222204B2 (en) Influenza inhibiting compositions and methods
Kido et al. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses
MXPA96004207A (en) Novedous remedy for tractor pyrrato viral disease
RU2657523C2 (ru) Фармацевтический аэрозольный состав ингибиторов протеаз с озон-сберегающим пропеллентом и его получение
JPWO1995025539A1 (ja) 新規気道部ウイルス疾患治療剤
AU747723C (en) Prevention and/or treatment of allergic conditions
AU2008269081B2 (en) Influenza inhibiting compositions and methods
WO2022139764A2 (en) Development of an innovative inhalation formulation of nafamostat mesylate for the management of covid-19
EA040577B1 (ru) Комбинированный аэрозольный состав на основе ингибиторов протеаз и его получение
HK1142804B (en) Influenza inhibiting compositions and methods